Nuvem Acquires Louvir to Expand Advanced Analytics Capabilities.
Nuvem to integrate analytics as a core differentiator in fast-growing pharmacy services solution.
Mount Laurel, NJ–February 3, 2025–Today, Nuvem announces the acquisition of Louvir, a leading provider of pharmacy analytics for FQHCs and grantees. With this acquisition, Nuvem accelerates the development of its advanced analytics arm to best serve C-level executives and pharmacy leaders operating within the everchanging 340B landscape. Louvir helps organizations enhance visibility and program management, address compliance needs, and identify opportunities to improve capture rates and reduce leakage.
Adds Louvir founder Brad Becker, “Louvir is thrilled to join the Nuvem family to collaborate with their team of industry experts and leverage cutting-edge technology, advanced insights, and analytics to empower grantees to optimize their 340B Programs and enhance patient care.” Becker and team will join Nuvem this month and Louvir customers will continue to work with the team and product they know and trust.